BioSpace News Archive

Cash, cash equivalents and financial assets[1] amounted to €202.7m as of December 31, 2018

Science park leader to talk at UKSPA, Knowledge Exchange meeting & BioIntegrates

Cellular Biomedicine Group Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical company engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the closing of its previously announced registered direct offering of 1,200,000 shares of its common stock at a price of $2.50 per share

Oncoceutics, Inc., announces the expansion of its diverse collaborations across the National Institutes of Health (NIH) involving its imipridone family of anti-cancer compounds

CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids.